Cargando…

Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

OBJECTIVES: To characterize individual participant level response distributions to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration from 1979 to 2016. DESIGN: Individual participant data analysis. POPULATION: 23...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stone, Marc B, Yaseen, Zimri S, Miller, Brian J, Richardville, Kyle, Kalaria, Shamir N, Kirsch, Irving
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344377/ https://www.ncbi.nlm.nih.gov/pubmed/35918097 http://dx.doi.org/10.1136/bmj-2021-067606

Ejemplares similares

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
por: Kirsch, Irving, et al.
Publicado: (2008)

Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration
por: Huedo-Medina, Tania B, et al.
Publicado: (2012)

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
por: Stone, Marc, et al.
Publicado: (2009)

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018
por: Cook, Jack, et al.
Publicado: (2020)

Antidepressants and the Placebo Effect
por: Kirsch, Irving
Publicado: (2014)

An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials
por: Goyal, Rahul K., et al.
Publicado: (2022)

Placebo Effect in the Treatment of Depression and Anxiety
por: Kirsch, Irving
Publicado: (2019)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
por: Kirsch, Irving
Publicado: (2008)

Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018)

Monoclonal Antibodies and Fc‐Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration
por: Liu, Xiaomei I., et al.
Publicado: (2019)

Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs
por: Lenotti, Elisa, et al.
Publicado: (2021)

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
por: Rising, Kristin, et al.
Publicado: (2008)

Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials
por: Maneeton, Narong, et al.
Publicado: (2012)

Correction: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
por: Rising, Kristin, et al.
Publicado: (2009)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2021)

Payment for participation in clinical research: Review of proposals submitted to the ethics committees
por: Marathe, Padmaja A., et al.
Publicado: (2018)

Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
por: Kalaria, Shamir N, et al.
Publicado: (2019)

Abstract not submitted not submitted for online publication
Publicado: (2011)

Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010–2020
por: Zhang, Audrey D., et al.
Publicado: (2021)

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021)

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
por: Dores, Graça M., et al.
Publicado: (2019)

Attitudes of acceptability and lack of condemnation toward suicide may be predictive of post-discharge suicide attempts
por: Galynker, Igor, et al.
Publicado: (2015)

Expectations: How and when do they contribute to placebo analgesia?
por: Rosenkjær, Sophie, et al.
Publicado: (2022)

Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses
por: Juul, Sophie, et al.
Publicado: (2021)

Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
por: Buergler, Sarah, et al.
Publicado: (2023)

Use of Quantile Treatment Effects Analysis to Describe Antidepressant Response in Randomized Clinical Trials Submitted to the US Food and Drug Administration: A Secondary Analysis of Pooled Trial Data
por: Meyerson, William U., et al.
Publicado: (2023)

Participation of the elderly, women, and minorities in pivotal trials supporting 2011–2013 U.S. Food and Drug Administration approvals
por: Downing, Nicholas S., et al.
Publicado: (2016)

Love and Suicide: The Structure of the Affective Intensity Rating Scale (AIRS) and Its Relation to Suicidal Behavior
por: Yaseen, Zimri S., et al.
Publicado: (2012)

The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2023)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Abstract not submitted
Publicado: (2013)

Abstract not submitted
Publicado: (2013)

On Submitting to the JACMP
Publicado: (2014)

Respectfully Submitted
Publicado: (1903)

Cyberpharmacies and the role of the US Food And Drug Administration
por: Henney, Jane E
Publicado: (2001)

The US Food and Drug Administration’s Intersection with Dermatology
por: Luke, Markham C.
Publicado: (2022)

Are All Placebo Effects Equal? Placebo Pills, Sham Acupuncture, Cue Conditioning and Their Association
por: Kong, Jian, et al.
Publicado: (2013)

Providing open-label placebos remotely—A randomized controlled trial in allergic rhinitis
por: Kube, Tobias, et al.
Publicado: (2021)

Can Depression be Diagnosed by Response to Mother's Face? A Personalized Attachment-Based Paradigm for Diagnostic fMRI
por: Zhang, Xian, et al.
Publicado: (2011)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rhktndmooj1i6bovp4ql4rj4pi